PubMed=498076
Woods L.K., Morgan R.T., Quinn L.A., Moore G.E., Semple T.U., Stedman K.E.
Comparison of four new cell lines from patients with adenocarcinoma of the ovary.
Cancer Res. 39:4449-4459(1979)

PubMed=6277475
Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E., Moseley J.M., Martin T.J.
Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
Cancer Res. 42:1116-1119(1982)

PubMed=6582512; DOI=10.1073/pnas.81.2.568
Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=2714338; DOI=10.1016/0277-5379(89)90195-8
Andrews P.A., Murphy M.P., Howell S.B.
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells.
Eur. J. Cancer Clin. Oncol. 25:619-625(1989)